Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: An international, multicentre, randomised superiority trial

The Lancet

Volumn 386, Issue 9994, 2015, Pages 672-679

  Macle, Laurent ^a   Khairy, Paul ^a   Weerasooriya, Rukshen ^b   Novak, Paul ^c   Verma, Atul ^d   Willems, Stephan ^e   Arentz, Thomas ^f   Deisenhofer, Isabel ^g   Veenhuyzen, George ^h   Scavée, Christophe ⁱ   Jaïs, Pierre ^j   Puererfellner, Helmut ^k   Levesque, Sylvie ^a   Andrade, Jason G ^a   Rivard, Lena ^a   Guerra, Peter G ^a   Dubuc, Marc ^a   Thibault, Bernard ^a   Talajic, Mario ^a   Roy, Denis ^a   Nattel, Stanley ^a   more..

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL JUBILEE HOSPITAL   (Canada)

^d SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

ⁱ CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k KH der Elisabethinen   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY PSEUDOANEURYSM; FOLLOW UP; GROIN HEMATOMA; HEART ATRIUM FLUTTER; HEART TAMPONADE; HEMATURIA; HUMAN; HYPERTHYROIDISM; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PERICARDIAL EFFUSION; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; URINARY TRACT INFECTION; WHEEZING; ATRIAL FIBRILLATION; CLINICAL TRIAL; DIAGNOSTIC USE; DRUG EFFECTS; MIDDLE AGED; OPERATION DURATION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PULMONARY VEIN; SECONDARY PREVENTION; TREATMENT OUTCOME;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OPERATIVE TIME; PROPORTIONAL HAZARDS MODELS; PULMONARY VEINS; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84939466883     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60026-5     Document Type: Article

References (28)

1. CT January, LS Wann, JS Alpert et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 130 2014 e199 e267
2. H Calkins, KH Kuck, R Cappato et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society Heart Rhythm 9 2012 632 696
3. A Verma, L Macle, J Cox, AC Skanes Committee CCSAFG. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter Can J Cardiol 27 2011 60 66
4. DJ Wilber, C Pappone, P Neuzil et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial JAMA 303 2010 333 340
5. CA Morillo, A Verma, SJ Connolly et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial JAMA 311 2014 692 700
6. J Cosedis Nielsen, LS Mortensen, PS Hansen Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation N Engl J Med 368 2013 478 479
7. DL Packer, RC Kowal, KR Wheelan et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial J Am Coll Cardiol 61 2013 1713 1723
8. H Oral, C Pappone, A Chugh et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation N Engl J Med 354 2006 934 941
9. A Verma, F Kilicaslan, E Pisano et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction Circulation 112 2005 627 635
10. F Ouyang, M Antz, S Ernst et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique Circulation 111 2005 127 135
11. S Willems, D Steven, H Servatius et al. Persistence of pulmonary vein isolation after robotic remote-navigated ablation for atrial fibrillation and its relation to clinical outcome J Cardiovasc Electrophysiol 21 2010 1079 1084
12. T Arentz, L Macle, D Kalusche et al. "Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation J Cardiovasc Electrophysiol 15 2004 1041 1047
13. T Datino, L Macle, XY Qi et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins Circulation 121 2010 963 972
14. T Datino, L Macle, D Chartier et al. Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: a clinical-experimental correlation Heart Rhythm 8 2011 1426 1433
15. S Matsuo, T Yamane, T Date et al. Reduction of AF recurrence after pulmonary vein isolation by eliminating ATP-induced transient venous re-conduction J Cardiovasc Electrophysiol 18 2007 704 708
16. H Hachiya, K Hirao, A Takahashi et al. Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation J Cardiovasc Electrophysiol 18 2007 392 398
17. LJ Gula, D Massel, P Leong-Sit et al. Does adenosine response predict clinical recurrence of atrial fibrillation after pulmonary vein isolation? J Cardiovasc Electrophysiol 22 2011 982 986
18. AJ McLellan, S Kumar, C Smith, JB Morton, JM Kalman, PM Kistler The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a systematic review J Cardiovasc Electrophysiol 24 2013 742 751
19. L Macle, P Khairy, A Verma et al. Adenosine following pulmonary vein isolation to target dormant conduction elimination (ADVICE): methods and rationale Can J Cardiol 28 2012 184 190
20. WJ Conover, RL Iman Analysis of covariance using the rank transformation Biometrics 38 1982 715 724
21. DG Wyse, AL Waldo, JP DiMarco et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
22. S Matsuo, T Yamane, T Date et al. Comparison of the clinical outcome after pulmonary vein isolation based on the appearance of adenosine-induced dormant pulmonary vein conduction Am Heart J 160 2010 337 345
23. S Miyazaki, T Kuwahara, A Kobori et al. Impact of adenosine-provoked acute dormant pulmonary vein conduction on recurrence of atrial fibrillation J Cardiovasc Electrophysiol 23 2012 256 260
24. T Datino, L Macle, D Chartier et al. Mechanism of differential effectiveness between pharmacological strategies to reveal dormant conduction during pulmonary vein isolation Heart Rhythm 8 2011 1426 1433
25. KH Kuck, VY Reddy, B Schmidt et al. A novel radiofrequency ablation catheter using contact force sensing: Toccata study Heart Rhythm 9 2012 18 23
26. S Haldar, JW Jarman, S Panikker et al. Contact force sensing technology identifies sites of inadequate contact and reduces acute pulmonary vein reconnection: a prospective case control study Int J Cardiol 168 2013 1160 1166
27. A Natale, V Reddy, G Monir et al. Paroxysmal atrial fibrillation catheter ablation with a contact force sensing catheter: results of the prospective multicenter SMART-AF trial J Am Coll Cardiol 64 2014 647 656
28. D Steven, A Sultan, V Reddy et al. Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial J Am Coll Cardiol 62 2013 44 50